maps • volume xvi number 2 • Autumn 2006
 
 
Sylvia Thyssen
sylvia@erowid.org
 

Clearly, the appreciation of reliable information about human experiences with psychoactive substances and the states of mind they engender is not limited to the proverbial psychonaut.


WEF Recipient: Sylvia Thyssen

Sylvia Thyssen sylvia@erowid.org

I was grateful to receive the Women’s Entheogen Fund award in 2003 and again in 2006. The field of progressive drug education is not well funded, and grants to individuals who facilitate important grassroots efforts are exceedingly rare.

Since my tenure at MAPS, my editing and administrative work has continued to focus on drug-related topics. In 2000, I briefly joined the DanceSafe national office. The most rewarding project I coordinated during that time was bringing a group of DanceSafe chapter leaders to a harm reduction conference in Miami, Florida.

In 2001, I began assisting Joel H. Brown and the Center for Education Research + Development (CERD)– perhaps best known for their pioneering work in resilience education as applied to drug education–with grant writing. CERD was producing an important drug reference manual for teachers to use in the classroom. I had the opportunity to guide the editing of this publication, relying on my deepening understanding of the disparate voices in drug information. In 2001, I also had the great opportunity to begin contributing to the Erowid Project. At that time, Erowid had some specific similarities to MAPS’ status when I began working there in 1993–a staff of one-to-two people and a growing membership base requiring increasing administrative oversight. As an information hub for a constantly shifting and growing world of drug research, both legally approved and illicit, Erowid faced other challenges as well. Large numbers of people were contacting the site daily with questions and submissions, the site’s complex structure required constant updating and maintenance, and new projects needed attention. For example, at that time, Erowid was asked to manage DanceSafe’s Ecstasy testing program, restructured as EcstasyData.org, a collaborative project between Erowid, MAPS and DanceSafe. Erowid also took on the multiyear digitization of the Hofmann Collection of LSD & Psilocybin References, a joint project with MAPS and the Albert Hofmann Foundation.

By 2003, I was working collaboratively with Fire, Earth and crew on document editing, site updates, membership development and volunteer management. I helped beta-test new tools that could support a growing number of donors, volunteers and submissions, and also helped identify new areas of content, such as Families & Psychoactives, Psychoactives & Sex, Death & Dying, and character vaults about little-known elders like Betty Eisner and Nina Graboi. As I continued to acquaint myself with the site’s demands, following the parallel paths of information architecture and content, I joked to friends about having become a psychedelic librarian. Embracing this curious role, I continue to nourish the knowledge systems that further the cause of research, and that bring people and information together.

My current focus is on raising awareness of how specific language used to describe psychoactive drugs and experiences can deeply imprint on the thoughts and actions of others, with a significant impact on not only individual, but societal understandings of psychoactive drugs. To this end, I authored “Rumor and Ethic: Careful Communication as a Harm Reduction Measure,” adapted from my presentation at the 2005 Mind States conference.

Today, Erowid is better equipped than ever to respond to the waves of data flooding the site from all sides, even as new challenges to its balance of resources arise. To test new waters, I am coordinating Erowid’s presence at the November 2006 American Public Health Association Expo in Boston. Clearly, the appreciation of reliable information about human experiences with psychoactive substances and the states of mind they engender is not limited to the proverbial psychonaut. Everyone benefits from collecting and sharing knowledge, and I look forward to continuing to cultivate an atmosphere of inquiry among Erowid visitors and volunteers.

Bulletin Archive Index
Winter 2009 Vol. 18, No. 3 MAPS 2008 Financial Report
Summer 2008 Vol. 18, No. 2 Phoenix Rising: A Review of MAPS Research
Winter 2008 Vol. 18, No. 1 Special Edition: Technology and Psychedelics
Winter 2007 Vol. 17, No. 3 MAPS 06-07 Fiscal Yearly Report
Autumn 2007 Vol. 17, No. 2 Special Edition: Psychedelics and Self-Discovery
Spring/Summer 2007 Vol. 17, No. 1 The Chrysalis Stage
Winter 2006-7 Vol. 16, No. 3 Low Maintenance/High Performance
Autumn 2006 Vol. 16, No. 2 Technologies of Healing
Spring 2006 Vol. 16, No. 1 MAPS' 20th Anniversary
Winter 2005 Vol. 15, No. 3 MAPS final year as a teenager
Summer 2005 Vol. 15, No. 2 Israel Conference: MDMA/PTSD Research
Spring 2005 Vol. 15, No. 1 Accelerating flow of work and time
Autumn 2004 Vol. 14, No. 2 Rites of Passage: Kids and Psychedelics
Summer 2004 Vol. 14, No. 1 10 stamps and $250,000
Winter 2003 Vol. 13, No. 2 Holy Fire
Spring 2003 Vol. 13, No. 1 60th Anniversary of the Discovery of LSD
Autumn 2002 Vol. 12, No. 3 Vision
Summer 2002 Vol. 12, No. 2 "From celebration to frustration, and back again."
Spring 2002 Vol. 12, No. 1 Sex, Spirit & Psychedelics 2002
Autumn 2001 Vol. 11, No. 2 "In the future, it will be called Despair."
Spring 2001 Vol. 11, No. 1 "A Tidal Wave of Ecstasy!"
Autumn 2000 Vol. 10, No. 3 Creativity 2000
Summer 2000 Vol. 10, No. 2 Endings and Beginnings
Spring 2000 Vol. 10, No. 1 Making History in Slow Motion
Winter 1999/00 Vol. 9, No. 4 To the Ends of the Earth for MDMA Research...
Autumn 1999 Vol. 9, No. 3 MAPS' long-standing efforts to conduct...
Summer 1999 Vol. 9, No. 2 MAPS has come full circle...
Spring 1999 Vol. 9, No. 1 Patience, persistence and passion
Winter 1998/99 Vol. 8, No. 4 One of special pleasures of directing MAPS...
Autumn 1998 Vol. 8, No. 3 The Ayahuasca Issue (with Hofmann interview)
Summer 1998 Vol. 8, No. 2 Emotionally Powerful Anecdotes...
Spring 1998 Vol. 8, No. 1 Death Has a Way of Focusing One's Attention
Autumn 1997 Vol. 7, No. 4 Celebration is in Order
Summer 1997 Vol. 7, No. 3 Time Horizons
Spring 1997 Vol. 7, No. 2 Synchronicity
Winter 1996/97 Vol. 7, No. 1 Learning to Crawl
Autumn 1996 Vol. 6, No. 4 An Invitation for Dialogue
Summer 1996 Vol. 6, No. 3 Budding Research
New Year 1996 Vol. 6, No. 2 Sending Down Roots
Autumn 1995 Vol. 6, No. 1 Baby Steps
Summer 1995 Vol. 5, No. 4 Opportunity Amidst Obstacles
Winter 1994/95 Vol. 5, No. 3 Clinical Trials and Tribulations
Autumn 1994 Vol. 5, No. 2 Building Towards Clinical Trials
Summer 1994 Vol. 5, No. 1 Politics and Protocols: In Search of a Balance
Spring 1994 Vol. 4, No. 4 Laying the Groundwork
Winter 1993/94 Vol. 4, No. 3 A Time of Tests
Summer 1993 Vol. 4, No. 2 So Close Yet So Far
Spring 1993 Vol. 4, No. 1 Remembrance and Renewal
Winter 1992/93 Vol. 3, No. 4 Forging New Alliances
Summer 1992 Vol. 3, No. 3 Building on Common Ground
Spring 1992 Vol. 3, No. 2 Small Steps, Gradual Progress, New Opportunities
Winter 1991/92 Vol. 3, No. 1 The Rekindling of a Thousand Points of Light
Summer 1991 Vol. 2, No. 2 MDMA protocol development with cancer patients
Winter 1990/91 Vol. 2, No. 1 MAPS' Swiss pharmacologically-assisted psychotherapy conference
Autumn 1990 Vol. 1, No. 3 What and Who is MAPS?
Summer 1989 Vol. 1, No. 2 Switzerland Leads the Way
Summer 1988 Vol. 1, No. 1 MDMA can become a legal medicine